Internal Nanobodies Tackle Cystic Fibrosis

A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores near-normal function in cystic fibrosis cells.
Source
Forbes
Opens original article in a new tab
